MIFH
NEO icon

Migdal Insurance & Financial Holdings’s NeoGenomics NEO Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-14,154
Closed -$683K – 643
2021
Q1 		$683K Buy
14,154
+8,783
+164% +$457K 0.01% 289
2020
Q4 		$289K Buy
+5,371
New +$243K ﹤0.01% 267

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Migdal Insurance & Financial Holdings's NEO Position: Q2 2021 in Review

Migdal Insurance & Financial Holdings sold out of NeoGenomics (NEO) in Q2 2021, closing a stake of 14,154 shares — an estimated $683K sold.

Migdal Insurance & Financial Holdings first reported a position in NEO in Q4 2020 and held it in 2 quarters. The position peaked at $683K in Q1 2021. 311 funds tracked by Wall St. Rank hold NEO as of Q2 2021.

  • Migdal Insurance & Financial Holdings reported no remaining NeoGenomics position as of Q2 2021 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 14,154 NeoGenomics shares in Q2 2021, an estimated $683K.
  • Migdal Insurance & Financial Holdings first reported a position in NeoGenomics in Q4 2020 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's NeoGenomics position peaked at $683K in Q1 2021.
  • 311 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2021.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2021, filed 4 Aug 2021.